{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:02:26Z","timestamp":1791925346373,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["RTG 2581"],"award-info":[{"award-number":["RTG 2581"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jlr.2024.100631","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:53:39Z","timestamp":1724457219000},"page":"100631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["The sphingosine kinase 2 inhibitors ABC294640 and K145 elevate (dihydro)sphingosine 1-phosphate levels in various cells"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0954-3527","authenticated-orcid":false,"given":"Agata","family":"Prell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Wigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Huwiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8703-3275","authenticated-orcid":false,"given":"Fabian","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1888-9595","authenticated-orcid":false,"given":"Burkhard","family":"Kleuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2024.100631_bib1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/15216540600871118","article-title":"Sphingosine and ceramide signalling in apoptosis","volume":"58","author":"Woodcock","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jlr.2024.100631_bib2","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.3390\/ijms22115793","article-title":"A\u00a0comprehensive review: sphingolipid metabolism and implications of disruption in sphingolipid homeostasis","volume":"22","author":"Quinville","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2024.100631_bib3","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s12276-023-01018-9","article-title":"Functional roles of sphingolipids in immunity and their implication in disease","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jlr.2024.100631_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jlr.2024.100631_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jlr.2024.100631_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1137893","article-title":"Sphingolipids in neurodegenerative diseases","volume":"17","author":"Pan","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jlr.2024.100631_bib7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cmet.2021.06.006","article-title":"Sphingolipids in metabolic disease: the good, the bad, and the unknown","volume":"33","author":"Green","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2024.100631_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jlr.2024.100631_bib9","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.3390\/cells10092175","article-title":"Sphingolipids: effectors and achilles heals in viral infections?","volume":"10","author":"Schneider-Schaulies","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jlr.2024.100631_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fcell.2019.00203","article-title":"Diverse facets of sphingolipid involvement in bacterial infections","volume":"7","author":"Kunz","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jlr.2024.100631_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jlr.2024.100631_bib12","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.bbamem.2006.08.007","article-title":"Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases","volume":"1758","author":"Hait","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2024.100631_bib13","doi-asserted-by":"crossref","first-page":"47408","DOI":"10.1074\/jbc.M307687200","article-title":"Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases","volume":"278","author":"Billich","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100631_bib14","doi-asserted-by":"crossref","first-page":"19513","DOI":"10.1074\/jbc.M002759200","article-title":"Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform","volume":"275","author":"Liu","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100631_bib15","doi-asserted-by":"crossref","first-page":"35257","DOI":"10.1074\/jbc.M203033200","article-title":"PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA)","volume":"277","author":"Johnson","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100631_bib16","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jlr.2024.100631_bib17","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2012.01.038","article-title":"Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis","volume":"148","author":"Chipuk","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2024.100631_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/acs.jmedchem.0c01664","article-title":"Small molecule inhibitors targeting biosynthesis of ceramide, the central hub of the sphingolipid network","volume":"64","author":"Skacel","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jlr.2024.100631_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.yexcr.2015.02.025","article-title":"Revisiting the sphingolipid rheostat: evolving concepts in cancer therapy","volume":"333","author":"Newton","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jlr.2024.100631_bib20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/381800a0","article-title":"Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate","volume":"381","author":"Cuvillier","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2024.100631_bib21","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.8456305","article-title":"Programmed cell death induced by ceramide","volume":"259","author":"Obeid","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jlr.2024.100631_bib22","article-title":"The key role of sphingolipid metabolism in cancer: new therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jlr.2024.100631_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2024.100631_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.697290","article-title":"Editorial: sphingolipids in infection control","volume":"9","author":"Seibel","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jlr.2024.100631_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc2875","article-title":"Sphingosine 1-phosphate and cancer","volume":"10","author":"Pyne","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jlr.2024.100631_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drudis.2015.09.013","article-title":"Sphingosine-1-phosphate signaling: unraveling its role as a drug target against infectious diseases","volume":"21","author":"Arish","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jlr.2024.100631_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.733387","article-title":"Therapeutic potential of SphK1 inhibitors based on abnormal expression of SphK1 in inflammatory immune related-diseases","volume":"12","author":"Bu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jlr.2024.100631_bib28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2174\/1381612825666190404115424","article-title":"Design of sphingosine kinases inhibitors: challenges and recent developments","volume":"25","author":"Magli","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jlr.2024.100631_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/acsbiomedchemau.2c00017","article-title":"Sphingosine kinase 2 inhibitors: rigid aliphatic tail derivatives deliver potent and selective analogues","volume":"2","author":"Pashikanti","year":"2022","journal-title":"ACS Bio Med. Chem. Au"},{"key":"10.1016\/j.jlr.2024.100631_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jlr.2024.100631_bib31","doi-asserted-by":"crossref","first-page":"14053","DOI":"10.1021\/bi011606i","article-title":"Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): structure-activity relationship of sphingosine1-phosphate receptors","volume":"40","author":"Im","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jlr.2024.100631_bib32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/acn3.52017","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: a practical review","volume":"11","author":"Coyle","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jlr.2024.100631_bib33","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1124\/mol.104.003681","article-title":"Specificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide (GT11) in primary cultured cerebellar neurons","volume":"66","author":"Triola","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jlr.2024.100631_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41598-021-04009-w","article-title":"The sphingosine 1-phosphate receptor 2\/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism","volume":"12","author":"Pitman","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100631_bib35","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1194\/jlr.M049759","article-title":"Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II","volume":"55","author":"Cingolani","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100631_bib36","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1021\/bi00443a002","article-title":"Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities","volume":"28","author":"Igarashi","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.jlr.2024.100631_bib37","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2147\/DDDT.S367612","article-title":"Recent progress in the development of opaganib for the treatment of Covid-19","volume":"16","author":"Smith","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jlr.2024.100631_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ab.2011.01.003","article-title":"A\u00a0rapid assay for assessment of sphingosine kinase inhibitors and substrates","volume":"411","author":"Kharel","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jlr.2024.100631_bib40","article-title":"Characterization of isoenzyme-selective inhibitors of human sphingosine kinases","volume":"7","author":"Gao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100631_bib41","doi-asserted-by":"crossref","first-page":"12892","DOI":"10.1021\/bi980744d","article-title":"N,N-dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide","volume":"37","author":"Edsall","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jlr.2024.100631_bib42","doi-asserted-by":"crossref","first-page":"52487","DOI":"10.1074\/jbc.M406512200","article-title":"Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720","volume":"279","author":"Allende","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100631_bib43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1006\/bbrc.1995.2684","article-title":"The signal modulator protein 14-3-3 is a target of sphingosine- or N,N-dimethylsphingosine-dependent kinase in 3T3(A31) cells","volume":"216","author":"Megidish","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jlr.2024.100631_bib44","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.str.2013.02.025","article-title":"Molecular basis of sphingosine kinase 1 substrate recognition and catalysis","volume":"21","author":"Wang","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.jlr.2024.100631_bib45","doi-asserted-by":"crossref","first-page":"38841","DOI":"10.1074\/jbc.M110.127993","article-title":"The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells","volume":"285","author":"Loveridge","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100631_bib46","first-page":"5962","article-title":"Discovery and evaluation of inhibitors of human sphingosine kinase","volume":"63","author":"French","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jlr.2024.100631_bib47","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1242\/jcs.189225","article-title":"Visualizing red blood cell sickling and the effects of inhibition of sphingosine kinase 1 using soft X-ray tomography","volume":"129","author":"Darrow","year":"2016","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.jlr.2024.100631_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2013.21","article-title":"Sphingosine kinase 1 promotes malignant progression in colon cancer and independently predicts survival of patients with colon cancer by competing risk approach in South Asian population","volume":"5","author":"Tan","year":"2014","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.jlr.2024.100631_bib49","first-page":"4548","article-title":"A\u00a0novel sphingosine kinase 1 inhibitor (SKI-5C) induces cell death of Wilms' tumor cells in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Li","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.jlr.2024.100631_bib50","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1111\/bph.15601","article-title":"Targeting sphingosine kinase-1 with the low MW inhibitor SKI-5C suppresses the development of endometriotic lesions in mice","volume":"178","author":"Rudzitis-Auth","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jlr.2024.100631_bib51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BJ20111929","article-title":"Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1","volume":"444","author":"Schnute","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.jlr.2024.100631_bib52","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1039\/c3md00201b","article-title":"Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells","volume":"4","author":"Byun","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.jlr.2024.100631_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114401","article-title":"Therapeutic potential of the sphingosine kinase 1 inhibitor, PF-543","volume":"163","author":"Yi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jlr.2024.100631_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.109.163444","article-title":"Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2","volume":"333","author":"French","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jlr.2024.100631_bib55","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.18632\/oncotarget.7693","article-title":"Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells","volume":"7","author":"McNaughton","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jlr.2024.100631_bib56","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1210\/en.2010-0420","article-title":"Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640","volume":"151","author":"Antoon","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.jlr.2024.100631_bib57","article-title":"Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100631_bib58","series-title":"Structure\u2013Activity Relationship Studies on Isoform Selective Sphingosine Kinase Inhibitors","author":"Congdon","year":"2016"},{"key":"10.1016\/j.jlr.2024.100631_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800298","article-title":"Synthesis and biological evaluation of sphingosine kinase 2 inhibitors with anti-inflammatory activity","volume":"352","author":"Vettorazzi","year":"2019","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.jlr.2024.100631_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109881","article-title":"Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis","volume":"79","author":"Schwalm","year":"2021","journal-title":"Cell Signal."},{"key":"10.1016\/j.jlr.2024.100631_bib61","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3390\/ijms19051498","article-title":"Downregulation of the S1P transporter spinster homology protein 2 (Spns2) exerts an anti-fibrotic and anti-inflammatory effect in human renal proximal tubular epithelial cells","volume":"19","author":"Blanchard","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2024.100631_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011842","article-title":"Sphingosine kinase 1\/S1P receptor signaling axis is essential for cellular uptake of Neisseria meningitidis in brain endothelial cells","volume":"19","author":"Fohmann","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jlr.2024.100631_bib63","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fcell.2019.00210","article-title":"Monitoring the sphingolipid de novo synthesis by stable-isotope labeling and liquid chromatography-mass spectrometry","volume":"7","author":"Wigger","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jlr.2024.100631_bib64","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1158\/1535-7163.MCT-15-0279","article-title":"The sphingosine kinase 2 inhibitor ABC294640 reduces the growth of prostate cancer cells and results in accumulation of dihydroceramides in\u00a0vitro and in\u00a0vivo","volume":"14","author":"Venant","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jlr.2024.100631_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2021.11.009","article-title":"Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition","volume":"24","author":"Bennett","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.jlr.2024.100631_bib66","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1099\/jgv.0.001245","article-title":"In\u00a0vitro and in\u00a0vivo roles of sphingosine kinase 2 during dengue virus infection","volume":"100","author":"Al-Shujairi","year":"2019","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.jlr.2024.100631_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2021.09.060","article-title":"The alleviating effect of sphingosine kinases 2 inhibitor K145 on nonalcoholic fatty liver","volume":"580","author":"Shi","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jlr.2024.100631_bib68","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bjh.16530","article-title":"Sphingosine kinase-2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl-1","volume":"190","author":"LeBlanc","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jlr.2024.100631_bib69","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s12276-023-01007-y","article-title":"TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1","volume":"55","author":"Fei","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jlr.2024.100631_bib70","doi-asserted-by":"crossref","first-page":"TPS191","DOI":"10.1200\/JCO.2021.39.6_suppl.TPS191","article-title":"Phase II trial of opaganib in patients with metastatic castration-resistant prostate cancer progressing on abiraterone or enzalutamide (NCT04207255)","volume":"39","author":"Kucuk","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jlr.2024.100631_bib71","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bbrc.2018.02.075","article-title":"Targeting sphingosine kinase 2 by ABC294640 inhibits human skin squamous cell carcinoma cell growth","volume":"497","author":"Zhou","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jlr.2024.100631_bib72","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1535-7163.MCT-13-0466","article-title":"Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma","volume":"13","author":"Qin","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jlr.2024.100631_bib73","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bbalip.2019.05.008","article-title":"Sphingosine kinase 2 is a negative regulator of inflammatory macrophage activation","volume":"1864","author":"Weigert","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jlr.2024.100631_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910767","article-title":"The sphingosine kinase 2 inhibitor ABC294640 restores the sensitivity of BRAFV600E mutant colon cancer cells to vemurafenib by reducing AKT-mediated expression of nucleophosmin and translationally-controlled tumour protein","volume":"22","author":"Grbcic","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2024.100631_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00222-18","article-title":"Native and polyubiquitinated forms of dihydroceramide desaturase are differentially linked to human embryonic kidney cell survival","volume":"38","author":"Alsanafi","year":"2018","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jlr.2024.100631_bib76","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00018-018-2984-8","article-title":"The role of dihydrosphingolipids in disease","volume":"76","author":"Magaye","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jlr.2024.100631_bib77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jdermsci.2013.03.006","article-title":"Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis","volume":"71","author":"Schaper","year":"2013","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.jlr.2024.100631_bib78","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2340\/00015555-3160","article-title":"Inhibiting sphingosine kinase 2 derived-sphingosine-1-phosphate ameliorates psoriasis-like skin disease via blocking Th17 differentiation of naive CD4 T lymphocytes in mice","volume":"99","author":"Shin","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jlr.2024.100631_bib79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.chemphyslip.2015.07.025","article-title":"Inhibitors of dihydroceramide desaturase 1: therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology","volume":"197","author":"Casasampere","year":"2016","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jlr.2024.100631_bib80","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1080\/15548627.2016.1213927","article-title":"Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization","volume":"12","author":"Hernandez-Tiedra","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.jlr.2024.100631_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101236","article-title":"The pathophysiological role of dihydroceramide desaturase in the nervous system","volume":"91","author":"Tzou","year":"2023","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jlr.2024.100631_bib82","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.bbalip.2018.08.015","article-title":"Molecular mechanisms of regulation of sphingosine kinase 1","volume":"1863","author":"Pulkoski-Gross","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jlr.2024.100631_bib83","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ab.2019.03.014","article-title":"Approaches for probing and evaluating mammalian sphingolipid metabolism","volume":"575","author":"Snider","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jlr.2024.100631_bib84","doi-asserted-by":"crossref","first-page":"27299","DOI":"10.1016\/S0021-9258(19)74249-5","article-title":"Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis\u00a0in\u00a0cultured neurons in situ","volume":"268","author":"Merrill","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100631_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111415","article-title":"De novo sphingolipid biosynthesis necessitates detoxification in cancer cells","volume":"40","author":"Spears","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2024.100631_bib86","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41375-021-01378-z","article-title":"3-Ketodihydrosphingosine reductase maintains ER homeostasis and unfolded protein response in leukemia","volume":"36","author":"Liu","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jlr.2024.100631_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316901","article-title":"Opaganib (ABC294640) induces immunogenic tumor cell death and enhances checkpoint antibody therapy","volume":"24","author":"Maines","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2024.100631_bib88","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2016.05.102","article-title":"Inhibition of ceramide glucosylation sensitizes lung cancer cells to ABC294640, a first-in-class small molecule SphK2 inhibitor","volume":"476","author":"Guan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524001366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524001366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T11:15:37Z","timestamp":1735643737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227524001366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":87,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0022227524001366"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100631","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The sphingosine kinase 2 inhibitors ABC294640 and K145 elevate (dihydro)sphingosine 1-phosphate levels in various cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100631"}}